How 908 Devices Inc. stacks up

MASS · against 557 other Healthcare companies listed in US-listed

Profitability

19/ 100

Below the middle of the pack.

Ranked #345 of 558 · scores higher than 37% of peers

Bars: peers in each 10-point band of the profitability score

114 peers with a profitability score of 10–19, including MASS · Click a bar to see the companies

Why profitability scores 19?

Weighted metrics compared with all Healthcare companies.

Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.

a lower return on invested capital: weaker than 88% of peers. Return on invested capital: -48.2% vs peer median 4.7%
a thinner operating margin: weaker than 85% of peers. Operating margin: -64.0% vs peer median 7.1%
a lower return on assets: weaker than 79% of peers. Return on assets: -17.5% vs peer median 1.7%

Metric by metric

Position: dot = MASS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	MASS	Peer median	Better than	Weight
Return on invested capitalHigher is better · 517 reported	-48.2%	-7.0%	25%	33%
Operating marginHigher is better · 479 reported	-64.0%	-2.4%	29%	33%
Return on assetsHigher is better · 582 reported	-17.5%	-7.8%	40%	33%
Return on equityHigher is better · 531 reported	-25.0%	-19.7%	48%	Context only
Gross marginHigher is better · 601 reported	52.7%	43.9%	56%	Context only

Ranking by profitability score

Top 5 and the companies ranked around MASS

Rank	Company	Market cap	Profitability	Overall
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	99	97
1	CorMedix Inc.CRMD · US-listed	433M USD	99	81
1	Exelixis, Inc.EXEL · US-listed	17.9B USD	99	76
1	IDEXX Laboratories, Inc.IDXX · US-listed	52.9B USD	99	57
1	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	99	73
⋯
335	The Oncology Institute, Inc.STLN · US-listed	646M USD	20	46
345	Beta Bionics, Inc.BBNX · US-listed	815M USD	19	53
345	Perspective Therapeutics, Inc.CATX · US-listed	100M USD	19	37
345	Design Therapeutics, Inc.DSGN · US-listed	647M USD	19	40
345	908 Devices Inc.MASS · US-listed	441M USD	19	34
345	Nanobiotix S.A.NBTX · US-listed	1.5B USD	19	32
345	Pacific Biosciences of California, Inc.PACB · US-listed	758M USD	19	35
345	Rapport Therapeutics, Inc.RAPP · US-listed	1.2B USD	19	40
345	Valneva SEVALN · US-listed	522M USD	19	12

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…